Portal de Periódicos da CAPES

The Human Rhodopsin Kinase Promoter in an AAV5 Vector Confers Rod- and Cone-Specific Expression in the Primate Retina

2012; Mary Ann Liebert, Inc.; Volume: 23; Issue: 10 Linguagem: Inglês

10.1089/hum.2012.125

1557-7422

Sanford L. Boye, John Alexander, Sanford L. Boye, C. Douglas Witherspoon, Kristen J. Sandefer, Thomas J. Conlon, Kirsten Erger, Jingfen Sun, Renee C. Ryals, Vince A. Chiodo, Mark E. Clark, Christopher A. Girkin, William W. Hauswirth, Paul D. Gamlin,

Retinal and Optic Conditions

Adeno-associated virus (AAV) has proven an effective gene delivery vehicle for the treatment of retinal disease. Ongoing clinical trials using a serotype 2 AAV vector to express RPE65 in the retinal pigment epithelium have proven safe and effective. While many proof-of-concept studies in animal models of retinal disease have suggested that gene transfer to the neural retina will also be effective, a photoreceptor-targeting AAV vector has yet to be used in the clinic, principally because a vector that efficiently but exclusively targets all primate photoreceptors has yet to be demonstrated. Here, we evaluate a serotype 5 AAV vector containing the human rhodopsin kinase (hGRK1) promoter for its ability to target transgene expression to rod and cone photoreceptors when delivered subretinally in a nonhuman primate (NHP). In vivo fluorescent fundus imaging confirmed that AAV5-hGRK1-mediated green fluorescent protein (GFP) expression was restricted to the injection blebs of treated eyes. Optical coherence tomography (OCT) revealed a lack of gross pathology after injection. Neutralizing antibodies against AAV5 were undetectable in post-injection serum samples from subjects receiving uncomplicated subretinal injections (i.e., no hemorrhage). Immunohistochemistry of retinal sections confirmed hGRK1 was active in, and specific for, both rods and cones of NHP retina. Biodistribution studies revealed minimal spread of vector genomes to peripheral tissues. These results suggest that AAV5-hGRK1 is a safe and effective AAV serotype/promoter combination for targeting therapeutic transgene expression protein to rods and cones in a clinical setting. Boye and colleagues evaluate adeno-associated viral vector serotype 5 (AAV5) containing the human rhodopsin kinase (hGRK1) promoter for transduction of rod and cone photoreceptors in nonhuman primates. After subretinal injections, transgene expression was detected specifically at injection sites, and AAV5-neutralizing antibodies were not detected. hGRK1 activity was restricted to rods and cones.